デフォルト表紙
市場調査レポート
商品コード
1425510

グリコミックスまたは糖鎖生物学の世界市場レポート 2024年

Glycomics or Glycobiology Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
グリコミックスまたは糖鎖生物学の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

グリコミックスまたは糖鎖生物学の市場規模は近年急速に拡大しています。2023年の15億9,000万米ドルから2024年には18億4,000万米ドルへ、CAGR15.6%で拡大します。過去の成長の背景には、生体システム内の糖鎖に対する認識の高まり、糖鎖関連データベースおよびリソースの拡大、共同研究イニシアチブの増加、糖鎖合成および工学技術の進歩、糖鎖バイオマーカーの同定などがあります。

2023年のグリコミックスまたは糖鎖生物学市場シェアでは北米が最大地域でした。アジア太平洋は予測期間中に最も急成長する地域と予想されます。グリコミックスまたは糖鎖生物学市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界のグリコミックスまたは糖鎖生物学市場の促進要因と制約
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のグリコミックスまたは糖鎖生物学の市場規模実績と成長、2018年から2023年
  • 世界のグリコミックスまたは糖鎖生物学の市場規模と成長予測、2023年から2028年、2033年

第6章 市場セグメンテーション

  • 世界のグリコミックスまたは糖鎖生物学市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 酵素
  • キット
  • 試薬および化学薬品
  • 機器
  • 炭水化物
  • 世界のグリコミックスまたは糖鎖生物学市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 創薬と開発
  • 病気の診断
  • その他の用途
  • 世界のグリコミックスまたは糖鎖生物学市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 学術調査機関
  • 製薬会社およびバイオテクノロジー会社
  • 臨床検査室

第7章 地域および国の分析

  • 世界のグリコミックスまたは糖鎖生物学市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のグリコミックスまたは糖鎖生物学市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • グリコミックスまたは糖鎖生物学市場の競合情勢
  • グリコミックスまたは糖鎖生物学市場の企業プロファイル
    • Water Corporation
    • Aligent Technologies Inc.
    • Bruker Corporation
    • Merck Co. &KgaA
    • New England Biolabs Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r12741

Glycomics or Glycobiology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on glycomics or glycobiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for glycomics or glycobiology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The glycomics or glycobiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Enzymes; Kits; Reagents and Chemicals; Instruments; Carbohydrates
  • 2) By Application: Drug Discovery and Development; Disease Diagnostics; Other Applications
  • 3) By End-user: Academic Research Institutes; Pharmaceutical and Biotechnology Companies; Clinical Laboratories
  • Companies Mentioned: Water Corporation; Aligent Technologies Inc.; Bruker Corporation; Merck Co. & KgaA; New England Biolabs Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Glycomics or glycobiology encompasses the exploration of saccharides' structures, biosynthesis, and biological functions, delving into the intricate world of sugar chains or glycans widely present in natural systems. These glycans are thoroughly examined within the realm of glycobiology for their structural composition, production processes, and biological significance.

The primary products associated with glycomics or glycobiology include enzymes, kits, reagents and chemicals, instruments, and carbohydrates. Enzymes, as biological polymers, serve as catalysts for biochemical reactions. These products find application across various domains such as drug discovery and development, disease diagnostics, among others, and are extensively utilized within academic research institutes, pharmaceutical and biotechnology companies, as well as clinical laboratories.

The glycomics or glycobiology market research report is one of a series of new reports from The Business Research Company that provides glycomics or glycobiology market statistics, including glycomics or glycobiology industry global market size, regional shares, competitors with a glycomics or glycobiology market share, detailed glycomics or glycobiology market segments, market trends and opportunities, and any further data you may need to thrive in the glycomics or glycobiology industry. This glycomics or glycobiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.59 billion in 2023 to $1.84 billion in 2024 at a compound annual growth rate (CAGR) of 15.6%. Historical growth can be attributed to the heightened awareness of glycans within biological systems, the expansion of glycan-related databases and resources, an increase in collaborative research initiatives, advancements in glycan synthesis and engineering techniques, and the identification of glycan biomarkers.

The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.38 billion in 2028 at a compound annual growth rate (CAGR) of 16.4%. The projected growth in the forecast period is driven by the advancement of glycan-focused artificial intelligence (AI) and data analytics, the expansion of glycobiology-based drug development, the integration of glycomics in disease biomarker discovery, and the utilization of personalized medicine and glycan-based therapeutics. Major trends expected during this period encompass cross-disciplinary collaborations between scientific fields, a deeper exploration of glycosylation patterns in disease mechanisms, the emergence of innovative precision medicine and personalized therapies utilizing glycobiology insights, advancements in glycoanalytical tools and technologies, and the utilization of glycans in the development of immunotherapy and vaccines.

The surge in demand for medications catering to severe chronic diseases is poised to drive the growth of the glycomics or glycobiology market. Chronic diseases, which persist over the long term without definitive cures, prompt extensive research into glycomics to understand glycosylation changes and their functional implications in drug development for these conditions. According to the American Cancer Society's Cancer Facts and Figures 2022-2024, the number of cancer survivors, considered a chronic disease, is projected to increase from 22.5 million in 2032 to an estimated 26 million by 2040. Hence, the escalating demand for medications to treat severe chronic diseases acts as a significant driver for the glycomics or glycobiology market.

The rising need for pharmaceutical products is expected to be a major driver for the growth of the glycomics or glycobiology market. These products encompass drugs specifically formulated to diagnose, prevent, treat, or cure various medical conditions. Glycomics and glycobiology play crucial roles in pharmaceutical development by elucidating disease mechanisms, identifying therapeutic targets, and optimizing drug design and effectiveness. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the total pharmaceutical production in Europe surged to $384,200 million (€340,000 million) in 2022, marking a significant 4.95% increase from the preceding year's $366,267 million (€323,950 million). Consequently, the heightened demand for pharmaceutical products acts as a catalyst propelling the glycomics or glycobiology market's growth.

A prevailing trend in the glycomics or glycobiology market is the emphasis on investments in research and development (R&D) endeavors. Prominent research institutions are channeling funding into glycobiology research centers, aiming to further advancements in glycomics or glycobiology. For instance, Griffith University's Institute for Glycomics unveiled the ACRF International center for Cancer Glycomics in August 2022. This pioneering facility, established with a $2.6 million ACRF grant, is dedicated to unraveling cancer glycocoding. It is envisioned as a unique resource, driving enhanced understanding of the glycocode and translating discoveries into clinical outcomes, ultimately improving the lives of cancer patients.

Leading companies within the glycomics or glycobiology market are innovating by developing cutting-edge products like glycan screening kits to cater to expanded customer bases and augment revenue streams. Glycan Screening Kits are specialized tools designed for comprehensive immunofluorescence detection of glycan expression in tissue sections, aiding researchers in characterizing complex glycans for insights into disease biomarkers and protein modifications. Vector Laboratories Inc., in July 2022, introduced its breakthrough product, the Glysite Scout Glycan Screening Kits. These fully integrated immunofluorescence kits offer robust capabilities for profiling glycan expression in tissue sections. The kits empower researchers to gain valuable insights into the significance of glycomics in samples, particularly in understanding post-translational protein modifications and disease biomarkers. With curated lectin selections, these kits enable the identification of major surface glycan motifs, enriching the understanding of disease progression, treatment impacts, and tissue characterization.

In January 2021, Neogen, a renowned US-based food safety company specializing in testing solutions for the food industry, completed the acquisition of Megazyme for an undisclosed sum. This strategic acquisition enabled Neogen to integrate Megazyme's product line into its portfolio, bolstering Neogen's position and enhancing its connections with key players in the food production and manufacturing sectors. Megazyme, headquartered in Ireland, is recognized for its expertise in developing and manufacturing analytical solutions, particularly in the realm of glycobiology enzyme products. Neogen's acquisition of Megazyme signifies a strategic move to expand its product offerings, leveraging Megazyme's specialized product line to further fortify Neogen's relationships with major food producers and corporations.

Major companies operating in the glycomics or glycobiology market report are Water Corporation, Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., S-BIO Pte. Ltd., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., Sumitomo Bakelite Co. Ltd., Bruker Corporation, AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., IEC Group Ltd., and R&D Systems Inc.

North America was the largest region in the glycomics or glycobiology market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the glycomics or glycobiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The glycomics or glycobiology market includes revenues earned by entities by maintaining tissue structure, porosity, and integrity. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Glycomics or Glycobiology Market Characteristics

3. Glycomics or Glycobiology Market Trends And Strategies

4. Glycomics or Glycobiology Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Glycomics or Glycobiology Market Size and Growth

  • 5.1. Global Glycomics or Glycobiology Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Glycomics or Glycobiology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Glycomics or Glycobiology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Glycomics or Glycobiology Market Segmentation

  • 6.1. Global Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Enzymes
  • Kits
  • Reagents and Chemicals
  • Instruments
  • Carbohydrates
  • 6.2. Global Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Discovery and Development
  • Disease Diagnostics
  • Other Applications
  • 6.3. Global Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Clinical Laboratories

7. Glycomics or Glycobiology Market Regional And Country Analysis

  • 7.1. Global Glycomics or Glycobiology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Glycomics or Glycobiology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Glycomics or Glycobiology Market

  • 8.1. Asia-Pacific Glycomics or Glycobiology Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Glycomics or Glycobiology Market

  • 9.1. China Glycomics or Glycobiology Market Overview
  • 9.2. China Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Glycomics or Glycobiology Market

  • 10.1. India Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Glycomics or Glycobiology Market

  • 11.1. Japan Glycomics or Glycobiology Market Overview
  • 11.2. Japan Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Glycomics or Glycobiology Market

  • 12.1. Australia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Glycomics or Glycobiology Market

  • 13.1. Indonesia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Glycomics or Glycobiology Market

  • 14.1. South Korea Glycomics or Glycobiology Market Overview
  • 14.2. South Korea Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Glycomics or Glycobiology Market

  • 15.1. Western Europe Glycomics or Glycobiology Market Overview
  • 15.2. Western Europe Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Glycomics or Glycobiology Market

  • 16.1. UK Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Glycomics or Glycobiology Market

  • 17.1. Germany Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Glycomics or Glycobiology Market

  • 18.1. France Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Glycomics or Glycobiology Market

  • 19.1. Italy Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Glycomics or Glycobiology Market

  • 20.1. Spain Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Glycomics or Glycobiology Market

  • 21.1. Eastern Europe Glycomics or Glycobiology Market Overview
  • 21.2. Eastern Europe Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Glycomics or Glycobiology Market

  • 22.1. Russia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Glycomics or Glycobiology Market

  • 23.1. North America Glycomics or Glycobiology Market Overview
  • 23.2. North America Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Glycomics or Glycobiology Market

  • 24.1. USA Glycomics or Glycobiology Market Overview
  • 24.2. USA Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Glycomics or Glycobiology Market

  • 25.1. Canada Glycomics or Glycobiology Market Overview
  • 25.2. Canada Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Glycomics or Glycobiology Market

  • 26.1. South America Glycomics or Glycobiology Market Overview
  • 26.2. South America Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Glycomics or Glycobiology Market

  • 27.1. Brazil Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Glycomics or Glycobiology Market

  • 28.1. Middle East Glycomics or Glycobiology Market Overview
  • 28.2. Middle East Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Glycomics or Glycobiology Market

  • 29.1. Africa Glycomics or Glycobiology Market Overview
  • 29.2. Africa Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Glycomics or Glycobiology Market Competitive Landscape And Company Profiles

  • 30.1. Glycomics or Glycobiology Market Competitive Landscape
  • 30.2. Glycomics or Glycobiology Market Company Profiles
    • 30.2.1. Water Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Aligent Technologies Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bruker Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck Co. & KgaA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. New England Biolabs Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Glycomics or Glycobiology Market Competitive Benchmarking

32. Global Glycomics or Glycobiology Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Glycomics or Glycobiology Market

34. Glycomics or Glycobiology Market Future Outlook and Potential Analysis

  • 34.1 Glycomics or Glycobiology Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Glycomics or Glycobiology Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Glycomics or Glycobiology Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer